BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12434133)

  • 1. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
    J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer.
    Vignaud JM; Marie B; Klein N; Plénat F; Pech M; Borrelly J; Martinet N; Duprez A; Martinet Y
    Cancer Res; 1994 Oct; 54(20):5455-63. PubMed ID: 7923179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
    Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
    Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human non-small cell lung cancer cells express a type 2 cytokine pattern.
    Huang M; Wang J; Lee P; Sharma S; Mao JT; Meissner H; Uyemura K; Modlin R; Wollman J; Dubinett SM
    Cancer Res; 1995 Sep; 55(17):3847-53. PubMed ID: 7641203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of MAGE-A1 expression with Ki-67 and tumor-infiltrating lymphocyte response in non-small cell lung carcinoma].
    Yue JQ; Diao LM; Li BY; Zou ZY; Xiao J; Chen DP; Fan LF; Guan J
    Ai Zheng; 2004 Feb; 23(2):219-22. PubMed ID: 14960250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes.
    Parekh K; Ramachandran S; Cooper J; Bigner D; Patterson A; Mohanakumar T
    Lung Cancer; 2005 Jan; 47(1):17-29. PubMed ID: 15603851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.
    Fukuyama T; Ichiki Y; Yamada S; Shigematsu Y; Baba T; Nagata Y; Mizukami M; Sugaya M; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
    Cancer Sci; 2007 Jul; 98(7):1048-54. PubMed ID: 17511773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
    Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF
    Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
    Su YJ; Ren K; Li H; Ren XB; Wang CL
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?
    Foukas PG; Tsilivakos V; Zacharatos P; Mariatos G; Moschos S; Syrianou A; Asimacopoulos PJ; Bramis J; Fotiadis C; Kittas C; Gorgoulis VG
    Anticancer Res; 2001; 21(4A):2609-15. PubMed ID: 11724329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
    Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
    Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic properties of CD4(+) T-cell clones which lyse HLA class II negative autologous non-small-cell lung cancer cells.
    Semino C; Ferlazzo G; Ratto GB; Melioli G
    Cell Immunol; 1999 Sep; 196(2):87-94. PubMed ID: 10527560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
    Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
    Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.